Clinical Trial Update: Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain [Phase 3]

View source ↗

Summary

Phase 3 trial update on oxymorphone extended release in opioid-experienced patients with chronic non-malignant pain reports efficacy and safety data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Oxymorphone Extended Release (oxymorphone)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Chronic Pain | Phase 3 | Status: COMPLETED